SPP1 and CD44

  • Number of citations of the paper that reports this interaction (PMID 10657301)
  • 144
  • Data Source:
  • HPRD (in vitro)

SPP1

CD44

Gene Name secreted phosphoprotein 1 CD44 molecule (Indian blood group)
Image
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
  • Response to Vitamin E supplementation ( 22437554)
  • Systemic lupus erythematosus ( 23273568)
  • Thiazide-induced adverse metabolic effects in hypertensive patients ( 23400010)
  • Vitiligo ( 22561518)
Protein-Protein Interactions 88 interactors: ABCF3 ACP5 AFF4 AMOTL2 APOA1 ATP2A2 ATP5F1 BAG6 BRD3 C1RL C2orf50 CACNG4 CALM1 CC2D1B CD44 CEP162 CHD1 CISD2 CMTM3 COMMD1 COPS5 CSNK2A1 CSNK2A2 CTNNBL1 CYB5R3 DCX DNAJB1 DNTTIP2 DSEL EEF1A1 EIF3K EPAS1 F2 FTH1 GRIPAP1 HBA2 HMGN1 IGFBP5 ITGA5 ITGA9 ITGAV ITGB1 KCNIP1 LRRC4 MAP1A MAP1B MARCKS MEOX2 MMP3 MMP7 MPPED1 MRPL23 NACA NCKAP1 NCSTN PDLIM7 PEMT PEPD PLD3 PRKACB PRKCA PRKG1 RANBP9 RAPGEF2 RBBP6 RIMS4 RPL13 RPL15 RPL5 RPS13 SEC24C SGTA SLC39A6 SNAPIN SSB STAU1 STK39 TBC1D8 TMEM168 TMEM30A TPT1 TTC1 TUBB UBQLN4 USP42 USP8 ZNF638 ZNF804A 39 interactors: ANK1 ARHGEF1 ARHGEF12 CD4 CD74 COL14A1 COL1A1 COL1A2 CSK DMP1 EGFR EPB41 ERBB4 EZR FGF2 FN1 FYN GARS HBEGF HMMR IGFBP3 LCK MADCAM1 MMP1 MMP7 MMP9 MSN NF2 PKN1 SELE SPP1 SRC SRGN TGFBR1 TGFBR2 TIAM1 VAV2 VCAN VHL
Entrez ID 6696 960
HPRD ID 01325 00115
Ensembl ID ENSG00000118785 ENSG00000026508
Uniprot IDs B7Z351 P10451 Q3LGB0 P16070
PDB IDs 3CXD 3DSF 1POZ 1UUH 2I83
Enriched GO Terms of Interacting Partners?
Tagcloud ?
able  acquisition  acts  carcinomas  cbx7  chemokine  contributing  counteracts  decreases  encoding  fact  hmga1b  inducing  interacting  interferes  involves  malignant  member  modulation  osteopontin  played  polycomb  progressively  relation  repressive  suppose  take  transcriptional  whose 
acute  aml  blastic  cml  elevated  hematologic  immunosorbent  implications  kda  leukemia  lymphoid  marker  ml  monitoring  monoclonal  myelodysplastic  myeloid  nearly  neoplasias  ng  phases  reached  remission  scd44  serum  slightly  soluble  syndromes  volunteers 
Tagcloud (Difference) ?
able  acquisition  acts  carcinomas  cbx7  chemokine  contributing  counteracts  decreases  encoding  fact  hmga1b  inducing  interacting  interferes  involves  malignant  member  modulation  osteopontin  played  polycomb  progressively  relation  repressive  suppose  take  transcriptional  whose 
acute  aml  blastic  cml  elevated  hematologic  immunosorbent  implications  kda  leukemia  lymphoid  marker  ml  monitoring  monoclonal  myelodysplastic  myeloid  nearly  neoplasias  ng  phases  reached  remission  scd44  serum  slightly  soluble  syndromes  volunteers 
Tagcloud (Intersection) ?